Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis

被引：6
|
作者：
Nichols, Derek [1 ]
Boyle, Theresa A. [2 ]
Noyes, David [1 ]
Latin, Kujtim [3 ]
Feygelman, Vladimir [3 ]
Jackson, Isabel [4 ]
Vujaskovic, Zeljko [4 ]
Antonia, Scott [1 ,5 ]
Perez, Bradford A. [1 ,2 ,3 ,5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA
[4] Univ Maryland, Div Translat Radiat Sci, Dept Radiat Oncol, Sch Med, Baltimore, MD 21202 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 11期
关键词：
CELL LUNG-CANCER; NIVOLUMAB; SAFETY; PEMBROLIZUMAB; CHEMORADIATION; RADIOTHERAPY; CARBOPLATIN; IRRADIATION; IPILIMUMAB; CONCURRENT;
D O I：
10.21037/jtd.2018.10.01
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：6254 / +
页数：8
相关论文
共 50 条
  • [41] Combining Anti-PD-1 (B7-H1) Immunotherapy with Stereotactic Radiosurgery in a Mouse Orthotopic Glioblastoma Model
    Zeng, J.
    See, A. P.
    Phallen, J.
    Belcaid, Z.
    Durham, N.
    Ford, E.
    Tran, P. T.
    Pardoll, D.
    Drake, C. G.
    Lim, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S82 - S83
  • [42] COMBINING ANTI-PD-1 (B7-H1) IMMUNOTHERAPY WITH STEREOTACTIC RADIOSURGERY IN A MOUSE ORTHOTOPIC GLIOBLASTOMA MODEL
    Zeng, Jing
    See, Alfred P.
    Phallen, Jillian
    Belcaid, Zineb
    Durham, Nicholas
    Meyer, Christian
    Albesiano, Emilia
    Pradilla, Gustavo
    Ford, Eric
    Hammers, Hans
    Tyler, Betty
    Brem, Henry
    Tran, Phuoc T.
    Pardoll, Drew
    Drake, Charles G.
    Lim, Michael
    NEURO-ONCOLOGY, 2011, 13 : 37 - 38
  • [43] Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion
    de Azevedo, Ricardo Alexandre
    Cheng-En, Hsieh
    Jayaprakash, Priyamvada
    Bhanu, Krithikaa Rajkumar
    Srinivasamani, Anupallavi
    Morrow, Brittany
    Winkler, Michelle
    Hedge, Shweta Mahendra
    Liu, Arthur
    Curran, Michael A.
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma
    Chen, Liqianqi
    Li, Zihuang
    Li, Xianming
    Wu, Shihai
    Gong, Long
    Xu, Gang
    Chen, Shanyi
    Zhang, Yucong
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [45] Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy
    Hirsch, Heather A.
    Pinheiro, Elaine M.
    Cai, Mingmei
    Ma, Yanhong
    Sathe, Manjiri
    Ayers, Mark
    McClanahan, Terrill K.
    CANCER RESEARCH, 2015, 75
  • [46] Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and Their Combined Immunotherapy in Clinical Trials: A Systematic Review and Meta-analysis
    Xiang, Ze
    Li, Jiayuan
    Zhang, Zhengyu
    Cen, Chao
    Chen, Wei
    Jiang, Bin
    Meng, Yiling
    Wang, Ying
    Berglund, Bjoern
    Zhai, Guanghua
    Wu, Jian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Receipt of Chest Radiation and Immune-Related Pneumonitis in Patients with NSCLC Treated with Anti-PD-1/PD-L1
    Voong, K. R.
    Hazell, S.
    Hu, C.
    Hayman, J.
    Hales, R.
    Marrone, K.
    Hann, C.
    Ettinger, D.
    Feliciano, J.
    Rowe, V.
    Kelly, R.
    Brahmer, J.
    Forde, P.
    Naidoo, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1837 - S1837
  • [48] Macrophages hijack anti-PD-1 therapy
    David Killock
    Nature Reviews Clinical Oncology, 2017, 14 : 394 - 394
  • [49] Expanding the Reach of Anti-PD-1 Therapy
    不详
    CANCER DISCOVERY, 2015, 5 (07) : 684 - 685
  • [50] CD40/anti-PD-1 sequential immunotherapy outperforms multiple immunotherapy combinations in an oral cancer prevention mouse model.
    Novaes, Jose A. Monteiro de Oliveira
    Poteete, Alissa
    Pisegna, Marlese
    William, William N.
    Heymach, John V.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
12345